Numbers of US indicators which were in the final UK indicator set
| No of indicators in US set | No of identical or near identical indicators in UK set | Main reason for discrepancy | |
|---|---|---|---|
| Acne | 4 | 1 | 2 indicators relate to iso-tretinoin treatment which can only be prescribed by specialists in the UK |
| Allergic rhinitis | 4 | 4 | |
| Asthma (excluding indicators for hospitalised patients) | 17 | 5 | Likely difference in panel process (see text) |
| Cervical screening | 7 | 3 | More frequent monitoring in US |
| Contraceptive treatment | 3 | 2 | |
| Coronary artery disease (excluding indicators for hospitalised patients) | 6 | 6 | |
| Depression | 17 | 9 | Some differences in requirement for recording, also differences relating to available specialist resources |
| Diabetes | 12 | 6 | More frequent monitoring recommended by US panel |
| Dyspepsia and peptic ulcer disease (excluding procedures during/following endoscopy) | 10 | 5 | Likely difference in panel process (see text) |
| Headache | 20 | 13 | Different clinical practice: less biomedical approach in UK |
| Hormone replacement treatment | 2 | 2 | |
| Hypertension | 12 | 8 | More frequent screening recommended by US panel |
| Influenza immunisation <50 years of age | 7 | 7 | |
| Low back pain | 14 | 8 | |
| Osteoarthritis | 7 | 4 | |
| Otitis media in children | 3 | 1 | |
| Respiratory tract infection | 11 | 3 | Majority of differences relate to increased propensity of US physicians to use antibiotics or to investigate |
| Urinary infection | 18 | 10 | More emphasis on investigation and follow up in US. Longer courses of antibiotics in US |
| Total | 174 | 98 |